Search results
Cancer drugs help drive AstraZeneca sales sharply higher
PA Media: Money via Yahoo Finance· 4 days agoAstraZeneca revealed soaring sales over the latest quarter as it was boosted by its cancer drugs....
AstraZeneca leaps after smashing first-quarter forecasts
Reuters via AOL· 5 days agoAstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday, boosted by...
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
Benzinga via Yahoo Finance· 4 days agoThursday, AstraZeneca Plc (NASDAQ:AZN) reported first-quarter sales of $12.68 billion, up 17% year...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 3 days agoThe first-quarter 2024 earnings season picked up pace this week, with Merck MRK, Sanofi SNY,...
Astrazeneca: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 4 days agoCAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Thursday reported first-quarter net income of $2.18 billion. The Cambridge, Britain-based company ...
Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 4 days agoWhile the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business...
What's Driving AstraZeneca PLC's Surprising 14% Stock Rally?
Guru Focus· 4 days agoAstraZeneca PLC (AZN, Financial) has recently seen a notable uptick in its stock performance, with a market capitalization now standing at a robust $231.04 billion. Over the ...
AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts
Simply Wall St. via Yahoo Finance· 3 days agoAs you might know, AstraZeneca PLC (LON:AZN) just kicked off its latest quarterly results with some...
ANGLE partners with AstraZeneca in groundbreaking oncology contract
Proactive Investors· 5 days agoANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive Andrew Newland joins Proactive's Stephen Gunnion...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoShares rise 2.1% to EUR89.67. (helena.smolak@wsj.com) 0708 ET – AstraZeneca’s first-quarter earnings were buoyed by sales of its cancer treatment drugs...
